Cargando…
Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine
Israel began administering a BNT162b2 booster dose to restore protection following the waning of the 2-dose vaccine. Biological studies have shown that a “fresh” booster dose leads to increased antibody levels compared to a fresh 2-dose vaccine, which may suggest increased effectiveness. To compare...
Autores principales: | Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008037/ https://www.ncbi.nlm.nih.gov/pubmed/35418201 http://dx.doi.org/10.1038/s41467-022-29578-w |
Ejemplares similares
-
Protection against Covid-19 by BNT162b2 Booster across Age Groups
por: Bar-On, Yinon M., et al.
Publicado: (2021) -
Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster
por: Amir, Ofra, et al.
Publicado: (2023) -
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2021) -
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
por: Bar-On, Yinon M., et al.
Publicado: (2022) -
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study
por: Amir, Ofra, et al.
Publicado: (2023)